Regenerative medicine – time to cut through the hype
This article was originally published in Clinica
Executive Summary
Regenerative medicine is widely seen as playing a vital future role in difficult-to-treat conditions like diabetes, Parkinson's disease and stroke. But can it really deliver on its promise, or is it simply being hyped up to persuade investors to put money into what is a young and unpredictable area of research?